Clovis to report third-quarter results Nov. 6
BOULDER —- Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its third quarter 2014 financial results on Thursday, Nov. 6, after the close of the U.S. financial markets.
Clovis’ senior management will host a conference call and live audio webcast at 2:30 p.m. that day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis’ website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
SPONSORED CONTENT
How dispatchable resources enable the clean energy transition
Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).
Boulder-based Clovis Oncology is a biopharmaceutical company that focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.
BOULDER —- Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its third quarter 2014 financial results on Thursday, Nov. 6, after the close of the U.S. financial markets.
Clovis’ senior management will host a conference call and live audio webcast at 2:30 p.m. that day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis’ website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
Boulder-based Clovis Oncology is a biopharmaceutical company that focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!